Wednesday, March 29, 2023


Biotechnology News Magazine


Luminex Receives BARDA $11.3 Mil In Funding

Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel

LabCentral Announces $22.4 M In Committed Funding for LabCentral 238 Including New Sponsors Thermo Fischer Scientific and Waters Corporation

LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced a total of $22.4 million in sponsorship commitments for LabCentral...

Evox Therapeutics Completes £69.2 Million Series C Financing

Financing round significantly oversubscribed by both new and existing investors. Proceeds enable advancement of our exosome therapeutics into the clinic and expansion of our world-leading exosome platform

Micronoma Raises $3.5 Million in Convertible Note Financing

February 17, 2021 Micronoma the first cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with...

Theravectys Secures $20M in Funding

With the current unmet need for vaccines that safely and effectively treat these diseases, there comes a need for a new approach to how these vaccines are created. Theravectys’ lentiviral vectors are engineered to elicit an unprecedented, efficient cellular immune response through direct in vivo transduction of dendritic cells.

Cambrian Biopharma Announces $60M in Financing

Cambrian Biopharma launch coincides with the IPO of its portfolio company Sensei Biotherapeutics, which began trading on February 4, World Cancer Day, through which Sensei raised approximately $133M in gross proceeds while seeing its market cap rise to about $600 million.